| ||
| Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and ... Takanami I. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis. Oncol Rep. 2004;12:849–853. ... www.ncbi.nlm.nih.gov/pmc/articles/PMC3095634/ | ||
| Clinical Care Options - Oncology CME - Introduction Providing Personalized Care in an Era of Molecular Medicine: Evolution in Non- Small-Cell Lung Cancer Diagnosis, Prognosis, and Treatment ... www.clinicaloptions.com/Oncology/.../Page%201.aspx | ||
| Paul Wheatley Price The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and ... 79.125.109.44/expert/uk/.../paul-wheatley-price-1491113.htm... | ||
| The prognostic value of FDG uptake of metastatic tumors in ... Objectives: Patients with advanced-stage of non-small cell lung cancer (NSCLC) have poor prognosis. A method of selecting patients who have a better ... jnumedmtg.snmjournals.org/cgi/content/meeting.../52/.../431 | ||
| Minamiya Y. Expression of histone deacetylase 1 correlates with a ... ... 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung. ... of non-small cell lung cancer (NSCLC) is not well understood. ... yale.pubget.com/paper/21466904 |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment